Danone: UBS reiterates buy recommendation
(CercleFinance.com) - Analysts deem Danone's H1 results as solid.
Danone reported current EEPS that is up 2.6% to E1.80 for H1 2024.
UBS reiterates its buy recommendation on the stock, with a target price of E72, representing 22% upside potential.
"LFL, vol/ mix, operating margin and EPS all ahead of consensus expectations despite adverse weather in Europe in Q2", UBS says.
Danone confirms its guidance for the full year 2024 of like-for-like sales growth of between +3 and +5%, and a moderate improvement in its current operating margin.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
Danone reported current EEPS that is up 2.6% to E1.80 for H1 2024.
UBS reiterates its buy recommendation on the stock, with a target price of E72, representing 22% upside potential.
"LFL, vol/ mix, operating margin and EPS all ahead of consensus expectations despite adverse weather in Europe in Q2", UBS says.
Danone confirms its guidance for the full year 2024 of like-for-like sales growth of between +3 and +5%, and a moderate improvement in its current operating margin.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.